Skip to main content

Table 6 Analysis of metabolic variables with the components of metabolic syndrome at 6-months

From: Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country

Outcome variables

Fat percentage Change tertiles (values)

HOMA-IR Change tertiles (values)

Adiponectin Change tertile (values)

Leptin Change tertile (values)

Leptin adiponectin ratio tertile (values)

Decreased

(−5.9 – −0.7)

Increased

(1.3–5.6)

Decreased

(−7.2–0.2)

Increased

(1.8–7.3)

Decreased

(−55.6 – −3.2)

Increased

(2.1–21.9)

Decreased

(−13.4 – −0.4)

Increased

(2.7–17.5)

Decreased

(−1.1 – −0.01)

Increased

(0.1–1.5)

MS

 Waist circumference (cm)

  Coeficient

−3.8

0.6

−0.1

2.5

−0.3

0.6

−0.1

2.7

−1.5

2.5

  95% CI

−6.2;-1.4

−1.7;2.8

−2.4; 2.3

0.1; 4.9

−2.9; 2.4

−2.2; 3.3

−2.6; 2.5

0.1; 5.3

−3.9; 0.9

0.1; 5.0

   P

0.003

0.623

0.950

0.041

0.850

0.668

0.963

0.041

0.218

0.042

 Blood Pressure (mmHg)

  Systolic BP

   Coeficient

0.1

−6.8

5.1

6.7

−3.5

−4.0

−3.5

−1.7

−7.3

−5.4

   95% CI

−9.2; 9.5

−15.5;1.9

−2.8; 13.1

−1.3; 14.6

−12.3; 5.3

−12.8; 4.8

−12.5; 5.6

−10.9; 7.5

−16.1; 1.6

−14.3; 3.6

    P

0.975

0.123

0.202

0.098

0.425

0.361

0.447

0.709

0.104

0.235

  Diastolic BP

   Coeficient

−5.6

−7.7

6.1

3.6

−2.9

2.2

−5.1

−0.2

−3.4

−3.5

   95% CI

−13.9; 2.6

−15.3;-0.0

−1.1; 13.3

−3.5; 10.8

−10.3; 4.5

−5.1; 9.6

−12.6; 2.4

−7.9; 7.4

−11.1; 4.2

−11.3; 4.2

    P

0.175

0.049

0.093

0.312

0.433

0.542

0.180

0.955

0.375

0.366

  Glucose

   Coeficient

0.3

1.9

−5.5

5.1

−2.0

−1.7

−6.9

1.7

−5.9

1.5

   95% CI

−6.4; 6.9

−4.4; 8.1

−10.4; −0.7

0.2; 10.0

−7.9; 4.0

−7.8; 4.4

−12.3; -1.5

−3.7;7.2

−11.5; 0.4

−4.1; 7.2

    P

0.936

0.549

0.027

0.043

0.509

0.568

0.013

0.529

0.037

0.590

  Triglycerides

   Coeficient

−3.8

−5.4

−3.6

30.0

9.4

1.7

−8.9

2.9

−40.7

−10.8

   95% CI

−37.7; 30.2

−37.6; 26.8

−31.5; 24.3

1.7; 58.3

−22.2; 41.0

−30.5; 33.8

−41.1; 23.2

−29.8; 35.5

−70.4; −11.1

−40.9; 19.4

    P

0.823

0.738

0.797

0.038

0.551

0.918

0.579

0.861

0.008

0.476

  HDL-C

   Coeficient

0.6

−1.8

2.4

3.6

−8.3

−0.5

1.0

3.0

2.6

0.3

   95% CI

−7.1; 8.4

−9.0; 5.4

−4.2; 9.0

−3.2; 10.4

−14.5; −2.1

−6.9; 5.9

−6.0; 8.0

−4.2; 10.2

−4.4; 9.6

−6.9; 7.6

    P

0.867

0.620

0.469

0.288

0.010

0.886

0.770

0.401

0.453

0.926

Adipokines

 Adiponectin

  Coeficient

0.1

−3.9

5.8

2.5

-

-

−1.2

−2.4

-

-

  95% CI

−4.0; 4.8

−9.0; 1.3

1.3; 10.3

−2.3; 7.3

  

−6.1; 3.8

−7.4; 2.6

  

   P

0.980

0.138

0.013

0.298

  

0.639

0.332

  

 Leptin

  Coeficient

0.3

1.4

−1.8

1.1

2.8

3.5

-

-

-

-

  95% CI

−4.3; 4.9

−2.9; 5.6

−5.5; 1.9

−2.8; 5.0

−0.8; 6.5

−0.2; 7.1

    

   P

0.895

0.511

0.331

0.569

0.130

0.063

    

Insulin resistance

 Fasting insulin (mμ/mL)

  Coeficient

−6.9

0.1

-

-

−1.1

−6.3

−4.1

2.5

−7.6

2.4

  95% CI

−12.7; -1.1

−5.8; 6.0

  

−7.8; 5.7

−13.2; 0.6

−11.1; 2.9

−4.6; 9.6

−14.1; −1.1

−4.3; 9.0

   P

0.020

0.978

  

0.753

0.072

0.241

0.480

0.023

0.476

 HOMA-IR

  Coeficient

1.8

1.7

-

-

−0.4

−1.7

−1.1

0.9

−2.2

0.8

  95% CI

0.1; 3.4

0.1; 3.4

  

−2.2; 1.5

−3.6; 0.2

−3.1; 0.8

−1.0; 2.9

−3.9; -0.4

−1.0; 2.6

   P

0.033

0.043

  

0.708

0.083

0.237

0.345

0.017

0.387

  1. Values obtained through robust linear regression analysis, adjusted for gender, age, treatment (only chemotherapy or chemotherapy plus radiotherapy), and and diagnoses (acute lymphoblastic leukemia or lymphoma). Regression coefficients are change in outcome variable per tertile change in fat percentage, HOMA-IR Adiponectin, leptin, and Leptin adiponectin ratio. The referent was stable tertile